Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Charnoly bodies could be a marker for cell damage, and certain nutrients and proteins might prevent them, potentially helping with brain diseases and cancer.

The study found a green method for strengthening hair works on all hair colors and is eco-friendly.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Two specific SNPs in the TRPS1 gene cause excessive hair growth by altering the protein's structure.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Ubiquitin, a protein, is found in hair, nails, and skin.

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Alopecia areata is more common in young Black African males, with rare other health issues.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Atopic diseases worsen alopecia areata, leading to earlier onset and more severe forms.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

Increasing zinc intake improved skin and hair symptoms in a rare genetic disorder.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Current treatments for alopecia show no significant long-term benefits.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.